- Home
- VERX vs BHVN Comparison
VERX vs BHVN Comparison
Compare VERX & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VERX | BHVN |
|---|---|---|
| Founded | 1978 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.0B |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | VERX | BHVN |
|---|---|---|
| Price | $12.94 | $15.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 14 |
| Target Price | $24.25 | ★ $29.08 |
| AVG Volume (30 Days) | 1.8M | ★ 4.0M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.08 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $748,444,000.00 | N/A |
| Revenue This Year | $12.78 | N/A |
| Revenue Next Year | $11.61 | N/A |
| P/E Ratio | $302.25 | ★ N/A |
| Revenue Growth | ★ 12.25 | N/A |
| 52 Week Low | $10.21 | $7.48 |
| 52 Week High | $36.75 | $18.57 |
Technical Indicators
Market Signals| Indicator | VERX | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 57.04 | 70.70 |
| Support Level | $12.41 | $8.54 |
| Resistance Level | $13.73 | $18.37 |
| Average True Range (ATR) | 0.62 | 1.01 |
| MACD | 0.15 | 0.17 |
| Stochastic Oscillator | 91.03 | 86.11 |
Price Performance
Historical ComparisonAbout VERX Vertex Inc.
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.